ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL

计划入组 40 人 · 首次发布于 2024 年 11 月 18 日

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

计划入组 250 人 · 首次发布于 2024 年 7 月 15 日

The TOGETHER Project - Kidney RNA-seq Validation

计划入组 302 人 · 首次发布于 2019 年 3 月 14 日

SEQ-9

SEQ-1274

SEQ-400

ANAND PRASAD

India

Shahed University

Iran

Aryogen Pharmed

Iran

Foresight Diagnostics and Roche Resolve Patent Dispute with PhasED-Seq Licensing Agreement for Non-Hodgkin's Lymphoma Diagnostics

Foresight Diagnostics Showcases Ultrasensitive MRD Technology in Multiple Lymphoma Studies at ASH 2025

Novel Cell-Free DNA Assays Enhance MRD Detection in Lymphoma Subtypes